Results 161 to 170 of about 533,812 (257)

Post-COVID syndrome in Pakistan, India, and Bangladesh: a systematic narrative review of epidemiology, clinical manifestations, and healthcare system responses. [PDF]

Front Public Health
Alrossies AS.
europepmc   +1 more source

Content validation of the nursing diagnosis “Adult Disuse Syndrome”: A quantitative study

International Journal of Nursing Knowledge, EarlyView.
Abstract Purpose This study aimed to establish the content validity of the proposed nursing diagnosis (ND) “Adult Disuse Syndrome” and all its components. Method This is an exploratory descriptive study of diagnostic content validation under Fehring's proposal.
Edinson Fabian Ardila‐Suárez, Vanessa Sánchez‐Martínez, Paula Escalada‐Hernández   +2 more
wiley   +1 more source

Determinants of healthcare utilisation among post-COVID syndrome patients: a population-based study in Malaysia. [PDF]

Sci Rep
Sha'ari NI, Ismail A, Sk Abd Razak R, Abdul Aziz AF, Suddin LS, Azzeri A, Zamli AH, Mohd Hanaffi RH.   +7 more
europepmc   +1 more source

The Effect of Benzodiazepines on Catatonia: A Systematic Review and Meta‐Analysis

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Catatonia is a complex psychomotor syndrome associated with various psychiatric and somatic underlying disorders. Current treatment protocols include benzodiazepines and electroconvulsive therapy (ECT). Despite their widespread use, systematic evidence regarding efficacy and optimal benzodiazepine dosage remains limited.
L. Bot, B. Schotsman, E. Oostra, A. W. Hoogendoorn, B. W. C. Storosum, C. H. M. Planting, H. M. Heller, J. J. B. van der Vlugt, J. G. van Mill, L. J. C. A. Smarius, M. S. Oudijn, M. S. van Noorden, S. M. M. Lange, Y. D. van der Werf, E. van Exel   +14 more
wiley   +1 more source

Subdomains of Post-COVID Syndrome (PCS) - a population-based study. [PDF]

BMC Infect Dis
Ballhausen-Lübcker S, Ruß AK, Lieb W, Schäfer A, Krist L, Fricke J, Scheibenbogen C, Rabe KF, Maetzler W, Maetzler C, Laudien M, Frank D, Heyckendorf J, Miljukov O, Haeusler KG, El Mokhtari NE, Witzenrath M, Vehreschild JJ, Appel KS, Chaplinskaya-Sobol I, Tamminga T, Nürnberger C, Schmidbauer L, Morbach C, Störk S, Reese JP, Keil T, Heuschmann P, Schreiber S, Krawczak M, Bahmer T.   +30 more
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Interpreting hand grip strength in hospital employees with post-COVID syndrome compared to non-infected controls: a case-control study. [PDF]

Sci Rep
Tack M, Gruber R, Betting L, Herbrandt S, Schlang G, Mattner F.   +5 more
europepmc   +1 more source

Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria

Allergy, EarlyView.
Ligelizumab re‐treatment in CSU patients showed sustained efficacy and tolerability. Over 50% achieved symptom control (UAS7 ≤ 6) by Week 12; benefits maintained through Week 52. No new safety signals observed; aligns with prior PEARL trial outcomes. CSU, chronic spontaneous urticaria; mg, milligram; q4w, every 4 weeks; UAS, urticaria activity score ...
Ana M. Gimenez‐Arnau, Marcus Maurer, Adam Reich, Chia‐Yu Chu, Diana Deleanu, Gordon Sussman, Jorge Sanchez, Knut Brockow, Koremasa Hayama, Michihiro Hide, Mohamed Denguezli, Raisa Meshkova, Roberta F. J. Criado, Sarbjit Saini, Solange Valle, Eva Hua, Pengpeng Wang, Alis Burciu, Isabelle Indermuehle, Vineeth Varanasi, Yolandi Joubert, Thomas Severin, Manmath Patekar   +22 more
wiley   +1 more source

Understanding post-COVID syndrome in healthcare workers: lessons for future pandemic response. [PDF]

Prim Health Care Res Dev
Abdouni L, Al-Hariri M, Doumat G, Radi C, Basbous L, Badr M, Atallah M, Bou Zerdan M, Tenbelian N, Bakhos N, Mansour P, Assaf G.   +11 more
europepmc   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source